<strong>认知药理学，历史与现状</strong>

摘要/Abstract

中图分类号:

R964

张均田，刘少林，蒋学英，楚世峰.认知药理学，历史与现状[J]. 神经药理学报, 2015, 5(1): 1-9.

张均田，刘少林，蒋学英，楚世峰. [J]. Acta Neuropharmacologica, 2015, 5(1): 1-9.

[1] Michael S Gazzaniga, Richard B Ivry, George Ronald Mangun. 周晓林，高定国等译. Cognitive neuroscience, the biology of the mind[M]. 第三版. 北京: 中国轻工业出版社, 2013.

[2] 刘芳, 褚波. 大脑与认知（修订版）[M]. 北京: 电子工业出版社, 2012.

[3] 唐孝威, 孙达, 水仁德, 等. 认知科学导论[M]. 北京: 科学出版社, 2007.

[4] Bernard J Baars, Nicole M Gage. Cognition, brain, and consciousness, second edition: introduction to cognitive neuroscience[M].第二版. 北京: 科学出版社, 2012.

[5] Sweatt J D. Mechanism of memory(second ed)[M].第二版. 北京: 科学出版社.

[6] 史忠植编著.认知科学[M]. 安徽: 中国科学技术大学出版社, 2008.

[7] 杨藻宸. 药理学总论[M]. 北京: 人民卫生出版社, 1989: 1-9.

[8] 张淑华, 朱启华, 杜庆东, 等.认知科学基础[M].北京: 科学出版社, 2007.

[9] 陈乃宏.神经递质与神经疾患[M].北京: 中国协和医科大学出版社, 2012： 1-18.

[10] 张庆柱, 张均田.书写世界现代医学史的巨人们—历届诺贝尔生理学或医学获奖者的传奇业绩和人生[M].北京: 中国协和医科大学出版社, 2006.

[11] 张均田, 张庆柱, 张永祥.神经药理学[M].北京: 人民卫生出版社, 2008.

[12] 韩济生.神经科学原理 [M]. 第二版. 北京: 北京医科大学出版社, 1999：268-283.

[13] 蔡禄. 表观遗传学前沿 [M].北京: 清华大学出版社, 2012.

[14] Day J J, Sweatt J D. Epigenetic treatments for cognitive impairments[J]. Neuropsycopharmacology, 2012, 37(1): 247-260.

[15] 张均田. 认知过程中的表观遗传学机制[J].中国药理学通报, 2015, 3(1): 1-6.

[16] 楚世峰, 张均田. 人参皂甙Rg1多靶点作用的共有机制[R].全国补益药专业委员会学术讨论会上大会报告, 太原, 2014.

[17] 黄倩, 楚世峰, 张均田. 人参皂甙Rg1的抗抑郁作用及其作用机制[J].神经药理学学报, 2014, 3(1): 1-11.

[18] 张均田.发现新药的药理学基础[M].北京: 北京化工出版社, 2002.

[19] 王玉珠, 王永胜, 楚世峰, 等. 人参皂甙Rg1促智信号转导途径研究[J].中国药理学通报, 2008, 24: 740-743.

[20] Chang Yi, Huang Wei-jan, Tien Lu-Tai, et al. Ginsenoside Rg1 and Rb1 enhance glutamate release through activation of protein A in rat cerebrocortical nerve terminals(synaptosomes) [J]. Eur J. Pharmacol, 2008, 578(1): 28-36.

[21] 张均田. 人参冠百草 [M]. 第二版.北京: 北京化学工业出版社, 2012：328-334.

[22] Hu Jin-Feng, Xue Wei, Ning Na, et al. Ginsenoside Rg1 activated CaMKⅡα mediated extracellular signal-regulated kinase/mitogen activated protein kinase signaling pathway[J]. Acta Pharmacol Sin, 2008, 29(9): 1119-1126.

[23] 张均田, 杜冠华. 现代药理实验方法 [M]. 第二版. 北京: 中国协和医科大学出版社, 2013：1326-1346.

[24] 中国药理学会编. 药理学学科发展报告（2010-2011）[M].北京: 科学出版社, 2011：127-142.

[25] Yang Y, Zhang J T, Shi C Z, et al. Study on the nootropic mechanism of ginsenoside Rb1 and Rg1. Influence on mouse brain development[J]. Acta Pharma Sin, 1994, 29(4): 241-245.

[26] Zhang J T. The retrospection and prospect of ginseng research[J]. Acta Pharmacol Sin, 1995, 20: 321-325.

[27] 申丽红, 张均田. 胎鼠神经干细胞培养方法的建立及药物对干细胞增殖的影响[J]. 药学学报, 2003, 38(10): 735-738.

[28] Shen Li-Hong, Zhang Jun-Tian. Ginsenoside Rg1 promotes proliferation of hippocampal progenitor cells[J]. Neurol Res, 2004, 26(4): 422-428.

[29] Shen Li-hong, Zhang Jun-tian. NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils[J]. Neurol Res, 2007, 29(3): 270-273.

[30] 张均田. 人参冠百草 [M]. 第二版. 北京: 北京化学工业出版社, 2012：295-306.

[31] Tang M, Feng W, Zhang Y, et al. Salvianolic acid B improves motor function after cerebral in rats[J]. Behav Pharmacol, 2006, 17(5-6): 493-498.

[32] Tang MK. Neuroprotective effects of salvianolic acid B. The chemistry, pharmacology and clinical therapeutic effects of Danshen( edited-in –chief by Zhang JT, Du GH)[M].化学工业出版社, 2013: 174-185.

[33] Zhong Jing, Qin Zhuan-di, Tang Ming-ke, et al. Sal B stimulates neurogenesis and angiogenesis in vitro and vivo[J]. Chinese Pharmacologist, 2005, 22(4): 9-10.

[34] Ing-Shiow Lay, Jen-Hwey Chiu, Shiao Ming-Shi, et al. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line[J]. Planta Med, 2003, 69(1): 26-32.

[35] Zhang Jun-Tian. The Chemistry and biological activates of (-)Clausenamide[M]. Beijing: Chemical Industry Press, 2013: 64-72.

[36] Jiang Xue-ying, Zhang Jun-tian. Study on the nootropic mechanism of (-)clausenamide-influence on the formation of synapses in mouse brain[J]. J Asian Nat Prod Res, 1998, 1(1): 53-58.

[37] Ning Na, Hu Jin-Feng, Sun Jian-Dong, et al. (-)Clausenamide facilitates synaptic transmission at hippocampal Schaffer collateral-CA1 synapses[J]. Eur J Pharmacol, 2012, 682(1-3): 50-55.

[38] 帕特丽夏.法拉, 卡拉琳.帕特森编, 户晓辉译.剑桥年度主题讲座：记忆[M].北京: 华夏出版社, 2011：128-129.

[39] Atkins C M, Selcher J C, Petraitis J J, et al. The MAPK cascade is required for mammalian associative learning[J]. Nat Neurosci, 1998, 1(7): 602-609.

[40] Emiliana Borrelli, Eric J Nestler, C David Allis, et al. Decoding the epigenetic language of neuronal plasticity[J]. Neuron, 2008, 60(6): 961-974.

[41] Brian Raught, Anne-Claude Gingras, Nahum Sonenberg. The target of rapamycin(TOR) proteins[J]. Proc Natl Acad Sci USA, 2001, 98(13): 7037-7044.

[42] Johannes Gräff, Isabelle M Mansuy. Epigenetic codes in cognition and behaviour[J]. Behav Brain Res, 2008, 192(1): 70-87.

[43] Paul L Greer, Michael E Greenberg. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function[J]. Neuron, 2008, 59（6）: 846-860.

[44] Jones M W, Errington M L, French P J, et al. A requirement for the immediate early gene Zif268 in the expression of Late LTP and long term memories[J]. Nat Neurosci, 2001, 4(3): 289-296.

[45] Karl Deisseroth, Richard W Tsien. Dynamic multiphosphorylation passwords for activity-dependent gene expression[J]. Neuron, 2002, 34: 179-182.

[46] Andreas Wenzel, Jean Marc Fritschy, Hanns Mohler, et al. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B and NR2C subunit proteins[J]. J Neurochem, 1997, 68(2): 469-478.

[47] Liu Li-dong, Wong Tak Pan, Mario F Pozza, et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity[J]. Science, 2004, 304(5763): 1021-1024.

[48] Lee H K, Barbarosie M, Kameyama K, et al. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity[J]. Nature, 2000, 405(6789): 955-959.

[49] Sheeja Navakkode, Sreedharsh Sajikumar, Julietta Uta Frey. The type Ⅳ-specific phosphor- diesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging[J]. J Neurosci, 2004, 24(35): 7740-7744.

[50] Tomok Ishibashi, Kelly A Dakin, Beth Stevens, et al. Astrocytes promote myelination in response to electrical impulses[J]. Neuron, 2006, 49(6): 823-832.

[51] Sara L Bengtsson, Zoltan Nagy, Stefan Skare, et al. Extensive paino practicing has regionally specific effects on white matter development[J]. Nat Neurosci, 2005, 8(9): 1148-1150.

[52] Martins D, Tavares I, Morgado C. “Hotheaded”: the role of TRPV1 in brain functions[J]. Neuropharmacology, 2014, 85: 151-157.

[53] Kauer J A,Gibson H E. Hot flash: TRPVchannels in the brain[J]. Trends Neurosci, 2009, 32(4): 215-224.

认知药理学，历史与现状

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

[1]	孙毅，谭博，苏瑞斌.偏向性配体——阿片类镇痛药设计新思路[J]. 神经药理学报, 2018, 8(2): 1-7.
[2]	王晋辉，黄丽，陈娜.大脑皮层GABA 能神经元缺血性损伤：易损性，机制和病理影响[J]. 神经药理学报, 2018, 8(2): 8-25.
[3]	杜冠华，张雯，杜立达，马寅仲，李莉，王月华.抗脑缺血药物研发现状分析与策略研究[J]. 神经药理学报, 2018, 8(1): 1-8.
[4]	林志彬.灵芝的抗衰老与抗阿尔茨海默病的药理研究进展[J]. 神经药理学报, 2018, 8(1): 9-15.
[5]	马娟，张法丽，钱忠明.铁调素和铁相关神经退行性疾病[J]. 神经药理学报, 2018, 8(1): 16-22.
[6]	杨燕飞，黄志力.特异性控制神经元活性法研究睡眠 -觉醒机制新进展[J]. 神经药理学报, 2018, 8(1): 23-34.
[7]	王允，镇学初.新型Sigma-1 受体变构调节剂的发现和潜在应用[J]. 神经药理学报, 2018, 8(1): 35-44.
[8]	肖婷，马天阳，徐祥清，王克威.大鼠慢性不可预测温和应激与小鼠社会挫败抑郁症模型的建立与行为学评价[J]. 神经药理学报, 2018, 8(1): 45-53.
[9]	昝桂影,孙翔，李庆林，刘景根 .κ阿片受体在抑郁中的作用及机制研究进展[J]. 神经药理学报, 2018, 8(1): 54-64.
[10]	张阔，杨静玉，吴春福.抑郁症的病理生理学基础及动物模型研究进展[J]. 神经药理学报, 2017, 7(4): 8-16.
[11]	任婧，张丹参.纳米给药系统脑靶向配体的研究进展[J]. 神经药理学报, 2017, 7(4): 17-25.
[12]	庞学波，薛茜，邹玉安.人血浆脂蛋白磷脂酶A2 与缺血性脑卒中的研究进展[J]. 神经药理学报, 2017, 7(4): 31-35.
[13]	万叶，郭春燕，李永民.中药在帕金森病领域的研究进展[J]. 神经药理学报, 2017, 7(4): 36-42.
[14]	王翠，郭童林，沈丽霞.植物雌激素在阿尔茨海默病中发挥神经保护作用的机制研究[J]. 神经药理学报, 2017, 7(4): 43-52.
[15]	白彦昌，贾艳丽，宋亚雪，王建华.阿尔茨海默病脑功能磁共振功能成像研究进展[J]. 神经药理学报, 2017, 7(3): 6-11.